Safety experience with IMC-C225, an anti-epidermal growth factor receptor antibody

被引：65

作者：

Needle, MN ^{[1
]}

机构：

[1] ImClone Syst Inc, Dept Clin Affairs, Somerville, NJ 08876 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 05期

关键词：

D O I：

10.1053/sonc.2002.35648

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：55 / 60

页数：6

共 18 条

[1]

ABBRUZZESE JL, 2001, P AN M AM SOC CLIN, V20, pA130

[2] Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin [J].

Baselga, J ;

Pfister, D ;

Cooper, MR ;

Cohen, R ;

Burtness, B ;

Bos, M ;

D'Andrea, G ;

Seidman, A ;

Norton, L ;

Gunnett, K ;

Falcey, J ;

Anderson, V ;

Waksal, H ;

Mendelsohn, J .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) :904-914

[3]

Baselga J, 2001, EUR J CANCER, V37, pS16

[4]

Bruns CJ, 2000, CLIN CANCER RES, V6, P1936

[5] Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial [J].

Burris, HA ;

Moore, MJ ;

Andersen, J ;

Green, MR ;

Rothenberg, ML ;

Madiano, MR ;

Cripps, MC ;

Portenoy, RK ;

Storniolo, AM ;

Tarassoff, P ;

Nelson, R ;

Dorr, FA ;

Stephens, CD ;

VanHoff, DD .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2403-2413

[6] Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225 [J].

Busam, KJ ;

Capodieci, P ;

Motzer, R ;

Kiehn, T ;

Phelan, D ;

Halpern, AC .

BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (06) :1169-1176

[7]

COHEN RB, 2000, P AN M AM SOC CLIN, V19, pA474

[8] Monoclonal antibodies to target epidermal growth factor receptor-positive tumors - A new paradigm for cancer therapy [J].

Herbst, RS ;

Shin, DM .

CANCER, 2002, 94 (05) :1593-1611

[9]

HONG WK, 2001, P AN M AM SOC CLIN, V20, pA224

[10]

Huang SM, 1999, CANCER RES, V59, P1935

← 1 2 →